VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,565,356 | +28.2% | 99,400 | +29.8% | 0.12% | +33.3% |
| Q2 2023 | $26,956,306 | +15.5% | 76,600 | +3.4% | 0.09% | +3.6% |
| Q1 2023 | $23,346,687 | +6.1% | 74,100 | -2.8% | 0.08% | +64.7% |
| Q4 2022 | $22,005,036 | -3.3% | 76,200 | -3.1% | 0.05% | +13.3% |
| Q3 2022 | $22,758,000 | -40.6% | 78,600 | -42.2% | 0.04% | -25.0% |
| Q2 2022 | $38,323,000 | -4.5% | 136,000 | -11.6% | 0.06% | +50.0% |
| Q1 2022 | $40,137,000 | +43.4% | 153,800 | +20.6% | 0.04% | +81.8% |
| Q4 2021 | $27,999,000 | -3.2% | 127,500 | -20.0% | 0.02% | -29.0% |
| Q3 2021 | $28,914,000 | -38.6% | 159,400 | -31.7% | 0.03% | -45.6% |
| Q2 2021 | $47,081,000 | +29.7% | 233,500 | +38.2% | 0.06% | +5.6% |
| Q1 2021 | $36,295,000 | +17.3% | 168,900 | +29.0% | 0.05% | 0.0% |
| Q4 2020 | $30,937,000 | +96.7% | 130,900 | +126.5% | 0.05% | +10.2% |
| Q3 2020 | $15,729,000 | -3.2% | 57,800 | +3.2% | 0.05% | -34.7% |
| Q2 2020 | $16,257,000 | +110.2% | 56,000 | +72.3% | 0.08% | +19.0% |
| Q1 2020 | $7,733,000 | -29.6% | 32,500 | -35.3% | 0.06% | -16.0% |
| Q4 2019 | $10,991,000 | -1.0% | 50,200 | -23.4% | 0.08% | -16.7% |
| Q3 2019 | $11,097,000 | +43.4% | 65,500 | +55.2% | 0.09% | +28.6% |
| Q2 2019 | $7,739,000 | -25.5% | 42,200 | -25.3% | 0.07% | -39.7% |
| Q1 2019 | $10,393,000 | -13.6% | 56,500 | -22.2% | 0.12% | +11.5% |
| Q4 2018 | $12,031,000 | -59.4% | 72,600 | -52.8% | 0.10% | -55.6% |
| Q3 2018 | $29,663,000 | +102.9% | 153,900 | +79.0% | 0.23% | +87.2% |
| Q2 2018 | $14,617,000 | -4.7% | 86,000 | -8.6% | 0.12% | -18.8% |
| Q1 2018 | $15,336,000 | +255.3% | 94,100 | +226.7% | 0.15% | +413.3% |
| Q4 2017 | $4,316,000 | -84.6% | 28,800 | -84.4% | 0.03% | -88.2% |
| Q3 2017 | $28,097,000 | +224.9% | 184,800 | +175.4% | 0.26% | +183.3% |
| Q2 2017 | $8,647,000 | +14.4% | 67,100 | -2.9% | 0.09% | +2.3% |
| Q1 2017 | $7,556,000 | +182.6% | 69,100 | +90.4% | 0.09% | +238.5% |
| Q4 2016 | $2,674,000 | +3.9% | 36,300 | +23.1% | 0.03% | -7.1% |
| Q3 2016 | $2,573,000 | +1.4% | 29,500 | 0.0% | 0.03% | -6.7% |
| Q2 2016 | $2,538,000 | -16.6% | 29,500 | -23.0% | 0.03% | -30.2% |
| Q1 2016 | $3,044,000 | -53.4% | 38,300 | -26.2% | 0.04% | -44.2% |
| Q4 2015 | $6,531,000 | +51.8% | 51,900 | +25.7% | 0.08% | +30.5% |
| Q3 2015 | $4,301,000 | +59.1% | 41,300 | +88.6% | 0.06% | +55.3% |
| Q2 2015 | $2,704,000 | -9.4% | 21,900 | -13.4% | 0.04% | -19.1% |
| Q1 2015 | $2,985,000 | -66.5% | 25,300 | -66.3% | 0.05% | -64.9% |
| Q4 2014 | $8,910,000 | +18.6% | 75,000 | +12.1% | 0.13% | +15.5% |
| Q3 2014 | $7,514,000 | -28.0% | 66,900 | -39.3% | 0.12% | -28.0% |
| Q2 2014 | $10,443,000 | +109.2% | 110,300 | +56.2% | 0.16% | +91.7% |
| Q1 2014 | $4,993,000 | -30.5% | 70,600 | -27.0% | 0.08% | -22.2% |
| Q4 2013 | $7,185,000 | +140.5% | 96,700 | +145.4% | 0.11% | +89.5% |
| Q3 2013 | $2,987,000 | -53.7% | 39,400 | -51.2% | 0.06% | -64.2% |
| Q2 2013 | $6,454,000 | – | 80,800 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 99,400 | $34,565,356 | 0.12% |
| SIMPLEX TRADING, LLC | 61,500 | $21,386 | 0.02% |
| IMC-Chicago, LLC | 47,900 | $16,656,746 | 0.02% |
| JANE STREET GROUP, LLC | 119,000 | $41,381,060 | 0.01% |
| Allianz Asset Management GmbH | 19,700 | $6,850,478 | 0.01% |
| SG Americas Securities, LLC | 59,600 | $593 | 0.01% |
| Maven Securities LTD | 900 | $312,966 | 0.00% |
| JPMORGAN CHASE & CO | 40,500 | $14,083,470 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $5,420 | 0.00% |